Sign In
Buy MLSS
$0.390
-0.0030 (-0.763%)
At Close: Jun 03, 2026
Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
12:00pm, Wednesday, 04'th Dec 2024
ROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
08:30am, Tuesday, 26'th Nov 2024
Contract Unlocks Significant Market Opportunities Across Federal Healthcare Systems Contract Unlocks Significant Market Opportunities Across Federal Healthcare Systems
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript
12:07pm, Friday, 15'th Nov 2024
Milestone Scientific Inc. (NYSE:MLSS ) Q3 2024 Earnings Call Transcript November 15, 2024 8:30 AM ET Company Participants David Waldman - Crescendo Communications, Investor Relations Arjan Haverhals -
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
04:30pm, Thursday, 14'th Nov 2024
Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
04:00pm, Thursday, 14'th Nov 2024
ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
08:30am, Tuesday, 12'th Nov 2024
ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to
Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE)
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price Assignment
11:00am, Thursday, 03'rd Oct 2024
Reports Robust Pipeline of Clinics in Trials Across Multiple States through Partnership with Axial Biologics Reports Robust Pipeline of Clinics in Trials Across Multiple States through Partnership wit
Milestone Scientific Inc. (MLSS) Q2 2024 Earnings Call Transcript
09:26am, Thursday, 15'th Aug 2024
Milestone Scientific Inc. (NYSE:MLSS ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants David Waldman - Investor Relations, Crescendo Communications Arjan Haverhals - C
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024
07:00am, Thursday, 15'th Aug 2024
Secured Medicare price assignment for the CompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 increased to 76.1% from 65.0% for the same period last year dri
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
11:00am, Monday, 12'th Aug 2024
ROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to
Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
10:00am, Wednesday, 07'th Aug 2024
ROSELAND, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
08:30am, Tuesday, 30'th Jul 2024
ROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
11:00am, Tuesday, 18'th Jun 2024
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain
